Source: European Journal of Cancer Care
Follow this link for fulltext.
Date of publication: January 2012
Publication type: article
In a nutshell: This paper challenges whether end-of-life care (EoLC) pathways facilitate the accomplishment of a ‘good death’. EoLC pathways are widely recommended as ‘best practice’. However there are concerns about the efficacy of care pathways with regard to their impact on patient care. Further examination of two EoLC pathways reveals how biomedical aspects of care are privileged. Despite this evidence indicates EoLC pathways may facilitate a particular type of ‘good death’, especially one associated with the dying process and framed within biomedicine.
Length of publication: 11 pages